Flexicann^®, CBD capsules

Flexicann^®

Food supplement 

Manufactured by Pharmaceutical EU GMP and FDA certified manufacturer.

Certification is available on request.
Under Novel Food registration process by EFSA*.

The product is registered by the Australian Government, Department of Health, Therapeutic Goods Administration (TGA).

Composition:

One capsule contains 40 mcg of UC-II®,20mg of Cannabidiol (purity 99,9%), 75 mcg of Vitamin K2 (Kaqpa), 5 mcg of vitamin D and 12 mg of Vitamin C.

Vitamin K2, D & C contribute to the maintenance of normal bones and the normal formation of connective tissue and collagen.

UC-II® is undenatured (native) type II collagen derived from chicken sternum cartilage by Lonza®:

• Trademarked, patented, scientifically studied ingredient

• Manufactured in USA under food GMP conditions

• Small dose (40 mg/once per day)

• Unique mechanism of action (Oral tolerance)

• Backed up by science

Scientific data available on request

Filled capsule weight is 225 mg, total weight of content is 175 mg.

*RDD-Recomended Daily Dose

Additives:

Bulking agent (microcrystalline cellulose), anti-caking agent (silicon dioxide), anti-caking agent ( magnesium stearate). For oral use only. Read the incrustations before use. Keep out of reach of children. Keep in a dark and dry place at the temperature up to 30 °C  in the original packaging to protect the product from light and moisture.

Recommended dosage:

1 capsule/day (in the morning, drink with water). The product is not suitable for children up to 3 years, pregnant and breastfeeding women.

Don’t exceed the recommended daily dose.

Detailed instructions included.

Product is not a substitute for a normal diet. Take care to have a balanced diet and healthy life style.

GMP/FDA certified manufacturing.

Storage:

Keep out of reach of children. Keep in a cold, dark and dry place at the temperature up to 30 °C in the original packaging to protect the product from light and moisture.

Shelf Life:
24 months.

* In November 2015, the European Parliament and the Council of the European Union adopted a new regulation on Novel Food, Regulation (EU) 2015/2283, with the intent of making the Novel Food authorization process more efficient while ensuring high standards of food safety or consumers. This new Regulation came into force on 1 January 2018. If lawfully marketed in the EU after 15 May 1997, existing Food Supplement products with Cannabidiol and/or Cannabis Sativa Extract can remain on the market as long as an application for Novel Food authorization is submitted to the European Commission before 1 January 2019.